A panel of biologically contained orthoebolaviruses for the screening of broad-spectrum antivirals
Jens Verlinden, Joren Stroobants, Jesus Sacramento Nonay…·Bert Vanmechelen
This study develops a biosafety level 2-compatible panel of orthoebolaviruses for screening broad-spectrum antivirals, identifying both broad-acting and virus-specific candidates.